(1R,3S,4R)-4-((3aR,9bR)-8-fluoro-7-(perfluoropropan-2-yl)-9b-(phenylsulfonyl)-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole-3-carbonyl)-3-methylcyclohexanecarboxylic acid

ID: ALA4763134

Chembl Id: CHEMBL4763134

PubChem CID: 146257125

Max Phase: Preclinical

Molecular Formula: C30H29F8NO5S

Molecular Weight: 667.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1C[C@H](C(=O)O)CC[C@H]1C(=O)N1CC[C@@]2(S(=O)(=O)c3ccccc3)c3cc(F)c(C(F)(C(F)(F)F)C(F)(F)F)cc3CC[C@@H]12

Standard InChI:  InChI=1S/C30H29F8NO5S/c1-16-13-18(26(41)42)7-9-20(16)25(40)39-12-11-27(45(43,44)19-5-3-2-4-6-19)21-15-23(31)22(14-17(21)8-10-24(27)39)28(32,29(33,34)35)30(36,37)38/h2-6,14-16,18,20,24H,7-13H2,1H3,(H,41,42)/t16-,18+,20+,24+,27+/m0/s1

Standard InChI Key:  ZRBKKZYWZRWOFL-GSDLGJSISA-N

Alternative Forms

  1. Parent:

    ALA4763134

    ---

Associated Targets(Human)

RORC Tchem Nuclear receptor ROR-gamma (8495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORB Tchem Nuclear receptor ROR-beta (600 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H3 Tchem LXR-alpha (2891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H2 Tchem LXR-beta (3841 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 667.62Molecular Weight (Monoisotopic): 667.1639AlogP: 6.47#Rotatable Bonds: 5
Polar Surface Area: 91.75Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.06CX Basic pKa: 0.49CX LogP: 6.44CX LogD: 3.32
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.37Np Likeness Score: 0.01

References

1. Shi Q,Xiao Z,Yang MG,Marcoux D,Cherney RJ,Yip S,Li P,Wu DR,Weigelt CA,Sack J,Khan J,Ruzanov M,Wang J,Yarde M,Ellen Cvijic M,Li S,Shuster DJ,Xie J,Sherry T,Obermeier M,Fura A,Stefanski K,Cornelius G,Chacko S,Shu YZ,Khandelwal P,Hynes J,Tino JA,Salter-Cid L,Denton R,Zhao Q,Dhar TGM.  (2020)  Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists - Exploring C6 and C8 SAR using late-stage functionalization.,  30  (23): [PMID:32882417] [10.1016/j.bmcl.2020.127521]

Source